Translate page

CML Guidelines

CML practitioners need dependable, well researched information to help make the best decisions for their CML patients. International therapeutic guidelines on the management of CML based on the latest research and written by leading CML experts provide a reliable and independent source of information. 

This section provides access to a selection of relevant international CML guidelines designed to assist you in the management of your CML patients. These guidelines include: 

  • European LeukemiaNet recommendations for the management of CML: 2013
  • NCCN Clinical Practice Guidelines in Oncology: CML version 1.2017
  • International BFM Group (iBFM): Managing children with CML 2014

If you have additional information to provide, please contact us at info@cml-foundation.org.

ELN Guidelines

European LeukemiaNet recommendations for the management of chronic myeloid leukemia 2013

Baccarani M et al. Blood 2013;122(6):872-884.

Click here to view a summary of the current ELN guidelines 

Executive Summary:

Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, mandate regular updating of concepts and management. A European LeukemiaNet expert panel reviewed prior and new studies to update recommendations made in 2009.

Elza Lomaia, Almazov Medical Research Centre, St. Petersburg, Russia


This Virtual Education Program, provided by the iCMLf in partnership with The Max Foundation, offers a series of webast presentations from leading hematologists. The sessions specifically address issues of CML care in countries with limited access to monitoring and supplemental treatments. To make the program also accessible for physicians from non-English speaking countries the iCMLf here also presents Spanish, French and Russian modules. We are very grateful for the support of Brandcast media to produce these web streams.

 

 

{rscomments off}

Patient-friendly summary of the 2013 ELN Guidelines 

A working group of CML patients from the CML Advocates Network, advised by medical experts, has developed a summary of the 2013 ELN recommendations in a patient-friendly language. This summary aims to help CML patients to discuss disease management and treatment choices with their doctors.

Available in 17 languages 

The patient-friendly summary is currently available in 17 different languages including Arabic, Bulgarian, Chinese, Danish, Dutch, English, French, German, Hebrew, Italian, Polish, Portuguese, Russian, Serbian, Spanish and Turkish.

Access the summaries on the website of the CML Advocates Network  

 

NCCN Guidelines 

Chronic Myelogenous Leukemia
National Comprehensive Cancer Network
Version 1.2017

Click here to view the NCCN Guidelines  

Once registered you will get a copy of the guidelines for your personal use only.

About NCCN

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.